Delayed Cord Clamping with Oxygen for Premature Birth
(DOXIE Trial)
Trial Summary
What is the purpose of this trial?
This trial tests whether giving preterm babies different oxygen levels while delaying umbilical cord clamping helps them breathe better. It focuses on very early preterm infants who often have trouble breathing. The goal is to see which method helps these babies get enough oxygen in their blood more quickly.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Delayed Cord Clamping with Oxygen for Premature Birth?
Research suggests that physiological-based cord clamping (PBCC), which is part of the treatment, helps stabilize blood flow and improve outcomes in very preterm infants by allowing better lung and heart function. Additionally, delayed umbilical cord clamping is known to increase blood volume in newborns, which can be beneficial for premature babies.12345
Is delayed cord clamping safe for premature infants?
How is the treatment of delayed cord clamping with oxygen for premature birth different from other treatments?
Delayed cord clamping with oxygen for premature birth is unique because it involves waiting to clamp the umbilical cord until the baby's lungs are working properly, which helps stabilize blood flow and reduce potential brain injury. This approach, known as physiological-based cord clamping (PBCC), contrasts with immediate cord clamping and aims to improve the baby's transition to life outside the womb.1251112
Research Team
Anup Katheria, MD
Principal Investigator
Sharp HealthCare
Eligibility Criteria
This trial is for preterm infants born up to 28+6 weeks gestational age, from any type of delivery and pregnancy. It's not for those with early membrane rupture before 20 weeks, congenital anomalies, fetal/maternal compromise, or if parents decline consent or resuscitation.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Infants receive delayed cord clamping with either high or low oxygen concentration for 90 seconds
Initial Monitoring
Infants are monitored for oxygen saturation, heart rate, and other vital signs in the first 24 hours of life
Follow-up
Participants are monitored for safety and effectiveness after the intervention, including assessments for sepsis, intraventricular hemorrhage, and other outcomes
Treatment Details
Interventions
- Delayed Cord Clamping with High Oxygen concentration (NA)
- Delayed Cord Clamping with Low Oxygen concentration (NA)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sharp HealthCare
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Dr. Diana W. Bianchi
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Executive Officer since 2016
MD from Stanford University
Dr. Alison Cernich
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Medical Officer since 2020
PhD in Clinical Psychology from University of Maryland
Sharp Mary Birch Hospital for Women & Newborns
Collaborator